drugset / Trial / NCT03932916
Safety and Pharmacokinetic of Donepezil Pamoate in Healthy Subjects
Non-randomizedSequentialOpen-labelTreatment
Summary
The objective of this study is to evaluate the safety and pharmacokinetic profiles of HHT201 in healthy subjects.
Timeline
- Start
- 2019-07-02
- Primary completion
- 2020-08-06
- Completion
- 2020-09-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Donepezil | Small molecule | 5 mg | Oral |
| Subject | Donepezil Pamoate | Unknown | 17 mg | Intramuscular |
| Subject | Donepezil Pamoate | Unknown | 34 mg | Intramuscular |
Indications
No indication recorded.